Literature DB >> 11992196

Psychomotor, executive, and memory function in preclinical Huntington's disease.

J S Snowden1, D Craufurd, J Thompson, D Neary.   

Abstract

The earliest changes in the development of Huntington's disease (HD) remain controversial. Studies of cognitive function in preclinical individuals who have the HD mutation have yielded contradictory results. This study compared cognitive and motor performance in 51 people with the HD mutation who had no clinical signs of HD, 85 at-risk individuals without the HD mutation and 43 individuals in the early stages of HD. Whereas highly significant differences were detected between the preclinical and early-HD groups, only subtle impairments were present in at-risk individuals with the HD mutation compared to those with normal HD alleles, principally for low-demand psychomotor tasks. Complementing these observations, longitudinal investigation showed that performance on psychomotor tasks in people with the mutation who were close to clinical onset of HD was intermediate between that of individuals many years from onset and those in the early stages of HD, suggesting a slowly insidious evolution of deficit. In contrast, memory performance showed a more precipitous decline around the time of clinical onset of HD. The findings, which suggest that HD patients' functional deficits do not evolve uniformly, help to resolve some of the disparities in the literature on preclinical HD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992196     DOI: 10.1076/jcen.24.2.133.998

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  45 in total

1.  Huntington's disease: changes in saccades and hand-tapping over 3 years.

Authors:  Chrystalina A Antoniades; Zheyu Xu; Sarah L Mason; R H S Carpenter; Roger A Barker
Journal:  J Neurol       Date:  2010-06-29       Impact factor: 4.849

Review 2.  The importance of considering all attributes of memory in behavioral endophenotyping of mouse models of genetic disease.

Authors:  Michael R Hunsaker
Journal:  Behav Neurosci       Date:  2012-06       Impact factor: 1.912

Review 3.  Brain imaging and cognitive dysfunctions in Huntington's disease.

Authors:  Alonso Montoya; Bruce H Price; Matthew Menear; Martin Lepage
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

4.  Visual scanning and cognitive performance in prediagnostic and early-stage Huntington's disease.

Authors:  Tanya Blekher; Marjorie R Weaver; Jeanine Marshall; Siu Hui; Jacqueline Gray Jackson; Julie C Stout; Xabier Beristain; Joanne Wojcieszek; Robert D Yee; Tatiana M Foroud
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

5.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Authors:  Jane S Paulsen; Jeffrey D Long; Christopher A Ross; Deborah L Harrington; Cheryl J Erwin; Janet K Williams; Holly James Westervelt; Hans J Johnson; Elizabeth H Aylward; Ying Zhang; H Jeremy Bockholt; Roger A Barker
Journal:  Lancet Neurol       Date:  2014-11-03       Impact factor: 44.182

6.  Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Authors:  Guerry M Peavy; Mark W Jacobson; Jody L Goldstein; Joanne M Hamilton; Amy Kane; Anthony C Gamst; Stephanie L Lessig; J C Lee; Jody Corey-Bloom
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

7.  Disrupted motor learning and long-term synaptic plasticity in mice lacking NMDAR1 in the striatum.

Authors:  Mai T Dang; Fumiaki Yokoi; Henry H Yin; David M Lovinger; Yanyan Wang; Yuqing Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

8.  The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease.

Authors:  Jirí Klempír; Olga Klempírová; Jan Stochl; Natasa Spacková; Jan Roth
Journal:  J Neurol       Date:  2009-05-16       Impact factor: 4.849

9.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.